Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLATYPUS: Sublingual vs Oral Olanzapine for Weight Gain
NCT00303602Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of olanzapine in schizophrenia, schizoaffective disorder, bipolar disorder (BD), sponsored by Eli Lilly and Company. Started Mar 2006; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophreniaschizoaffective disorderbipolar disorder (BD)
Beyond the preview
Go deeper on NCT00303602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303602.